0001209191-17-036145.txt : 20170530 0001209191-17-036145.hdr.sgml : 20170529 20170530164445 ACCESSION NUMBER: 0001209191-17-036145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170525 FILED AS OF DATE: 20170530 DATE AS OF CHANGE: 20170530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sierra Oncology, Inc. CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: ProNAi Therapeutics Inc DATE OF NAME CHANGE: 20040513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESTES DANIEL CENTRAL INDEX KEY: 0001702527 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 17877985 MAIL ADDRESS: STREET 1: C/O FRAZIER HEALTHCARE PARTNERS STREET 2: 601 UNION ST., SUITE 3200 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-25 0 0001290149 Sierra Oncology, Inc. SRRA 0001702527 ESTES DANIEL C/O FRAZIER HEALTHCARE PARTNERS 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 1 0 0 0 Stock Option (Right to Buy) 1.20 2017-05-25 4 A 0 50000 0.00 A 2027-05-25 Common Stock 50000 50000 D Stock options were granted in connection with the reporting person's appointment to the issuer's board of directors on April 10, 2017. The option vests as to 8.333% of the total shares monthly, beginning on June 25, 2017, with 100% of the total shares vested and exercisable on May 25, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Sukhi Jagpal as attorney-in-fact for Daniel Estes 2017-05-30